Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Medtronic Inc (MDT)

Medtronic Inc (MDT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 136,263,072
  • Shares Outstanding, K 1,344,215
  • Annual Sales, $ 28,913 M
  • Annual Income, $ 4,789 M
  • 60-Month Beta 0.67
  • Price/Sales 4.77
  • Price/Cash Flow 15.50
  • Price/Book 2.73
Trade MDT with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 21 analysts offering recommendations.
Earnings Estimates - Current Qtr 10/31/20
See More
  • Average Estimate 0.78
  • Number of Estimates 12
  • High Estimate 0.81
  • Low Estimate 0.76
  • Prior Year 1.31
  • Growth Rate Est. (year over year) -40.46%

Price Performance

See More
Period Period Low Period High Performance
1-Month
98.94 +1.65%
on 10/30/20
112.48 -10.59%
on 10/23/20
-3.35 (-3.22%)
since 09/30/20
3-Month
94.64 +6.27%
on 07/31/20
112.48 -10.59%
on 10/23/20
+4.10 (+4.25%)
since 07/30/20
52-Week
72.13 +39.43%
on 03/18/20
122.15 -17.67%
on 01/22/20
-7.98 (-7.35%)
since 10/30/19

Most Recent Stories

More News
Medtronic Receives Health Canada Licence for the First-of-Its-Kind Percept™ PC Neurostimulator with Brainsense™ Technology

Medtronic Receives Health Canada Licence for the First-of-Its-Kind Percept™ PC Neurostimulator with Brainsense™ Technology

MDT : 100.57 (-0.79%)
North America Medical Device Additives Manufacturing Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Technology, Products, and Application, and Country

, /PRNewswire/ -- Read the full report: The medical device additives manufacturing market is growing primarily due to increase in investments and expenditure on healthcare and advanced technologies in...

MDT : 100.57 (-0.79%)
Medtronic Expands ENT Portfolio with FDA Clearance of NIM Vital™ Next Generation Intraoperative Nerve Monitoring System and Acquisiton of Ai Biomed Corp.

, /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance of the NIM Vital™ nerve...

MDT : 100.57 (-0.79%)
United Therapeutics (UTHR) Q3 Earnings & Sales Beat Estimates

United Therapeutics' (UTHR) third-quarter earnings and sales beat estimates. Higher sales of Orenitram and Tyvaso offset lower sales of Remodulin and Adcirca.

MDT : 100.57 (-0.79%)
LLY : 130.46 (-1.58%)
UTHR : 134.23 (+3.06%)
CTLT : 87.77 (-1.81%)
IBM Study: AI-driven Virtual Agents Can Drive Customer Satisfaction and Cost Savings Amid COVID-19

, /PRNewswire/ -- As many organizations across the world look to digital tools to help address surges in customer inquiries due to the COVID-19 pandemic, a new revealed 99% of respondents report an increase...

IBM : 111.66 (+2.53%)
MDT : 100.57 (-0.79%)
Medtronic Venous Stent Receives U.S. FDA Approval to Treat Venous Outflow Obstruction

, /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received U.S. Food and Drug Administration (FDA) approval for the Abre™ venous self-expanding...

MDT : 100.57 (-0.79%)
Titan Medical Announces Achievement of $10 Million Technical Milestone Under Medtronic Development and License Agreement

Titan Medical Inc. ("Titan" or the "Company") (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design and development of surgical technologies for robotic single access surgery, announced...

TITXF : 0.1930 (-1.03%)
TMD.TO : 0.94 (-6.00%)
TMDI : 0.7000 (-6.67%)
MDT : 100.57 (-0.79%)
Medtronic Plc Rises 2.97% on Heavy Volume: Watch For Potential Pullback

Medtronic Plc (NYSE:MDT) traded in a range yesterday that spanned from a low of $111.31 to a high of $112.48. Yesterday, the shares gained 3.0%, which took the trading range above the 3-day high of $112.20...

MDT : 100.57 (-0.79%)
US Heart Valve Repair and Replacement Market Size | 2020, Growth Strategies, Opportunity, Challenges, Rising Trends and Revenue Analysis 2025

The delivers a succinct analysis on industry size, regional growth and revenue forecasts for the upcoming years. The report further sheds light on significant challenges and latest growth strategies adopted...

BSX : 34.27 (+2.30%)
CRY : 16.76 (-3.51%)
LIFE : 3.17 (-3.06%)
MDT : 100.57 (-0.79%)
NVCN.TO : 1.24 (-12.06%)
STJ : 80.82 (+0.16%)
Prosthetic Heart Valve/ Artificial Heart Valve Market Research: Growth Opportunities Regions, Types, Applications, Detail Research for Business Development Insights [2020-2025]

The Prosthetic Heart Valve/ Artificial Heart Valve Market is expected to exceed more than US$ 9 Billion by 2024 at a CAGR of 13% in the given forecast period.

CRY : 16.76 (-3.51%)
EW : 71.69 (-1.67%)
LIVN : 50.34 (-4.37%)
MDT : 100.57 (-0.79%)
NVCN.TO : 1.24 (-12.06%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Medtronic Public Limited Company, headquartered in Dublin, Ireland, is among the world's largest medical technology, services and solutions companies - alleviating pain, restoring health and extending life for millions of people around the world. The company is focused on collaborating with stakeholders...

See More

Key Turning Points

2nd Resistance Point 102.90
1st Resistance Point 101.73
Last Price 100.57
1st Support Level 99.17
2nd Support Level 97.78

See More

52-Week High 122.15
Fibonacci 61.8% 103.04
Last Price 100.57
Fibonacci 50% 97.14
Fibonacci 38.2% 91.24
52-Week Low 72.13

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar